Pediatric Liver Disease in India
Naresh Shanmugam, Malathy Sathyasekaran, Mohamed Rela – 4 July 2021
Pediatric Liver Disease in India
Naresh Shanmugam, Malathy Sathyasekaran, Mohamed Rela – 4 July 2021
The Pannexin 1/Purinergic Receptor P2X4 Pathway Controls the Secretion of MicroRNA‐Containing Exosomes by HCV‐Infected Hepatocytes
Ok‐Kyung Kim, Da‐eun Nam, Young S. Hahn – 3 July 2021
Genetic Disorders of Bile Acid Transport
Anne S. Henkel – 3 July 2021
REPLY:
Mimi Wong, Nirjhar Nandi – 3 July 2021
Proximal Splenic Artery Embolization to Treat Refractory Ascites in a Patient With Cirrhosis
Cristian Caporali, Laura Turco, Francesco Prampolini, Pietro Quaretti, Marcello Bianchini, Dario Saltini, Francesca Miceli, Federico Casari, Davide Felaco, Juan Carlos Garcia‐Pagan, Jonel Trebicka, Marco Senzolo, Gian Piero Guerrini, Fabrizio Di Benedetto, Pietro Torricelli, Erica Villa, Filippo Schepis – 3 July 2021
Sinusoidal Obstruction Syndrome in a Young Woman With Antiphospholipid Syndrome on Oral Contraceptives
Andrew P. Lange, Ayman A. Usmani, Christoph Wald, Fredric D. Gordon – 3 July 2021
Genetic Disorders of Bile Acid Transport
Anne S. Henkel – 3 July 2021
Genetic Variation in the Mitochondrial Glycerol‐3‐Phosphate Acyltransferase Is Associated With Liver Injury
Aaron Hakim, Matthew Moll, Joseph Brancale, Jiangyuan Liu, Jessica A. Lasky‐Su, Edwin K. Silverman, Silvia Vilarinho, Z. Gordon Jiang, Yered H. Pita‐Juárez, Ioannis S. Vlachos, Xuehong Zhang, Fredrik Åberg, Nezam H. Afdhal, Brian D. Hobbs, Michael H. Cho – 2 July 2021
Trends and Health Care Outcomes Among Living Liver Donors: Are We Ready to Expand the Donor Pool With Living Liver Donations?
Sajid Jalil, Sylvester M. Black, Ken Washburn, Neil Rangwani, Alice Hinton, Sean G. Kelly, Lanla Conteh, James Hanje, Anthony Michaels, Khalid Mumtaz – 1 July 2021 – We studied the trends and various outcomes, including the readmission rates, health care utilization, and complications among living liver donors (LLDs) in the United States. We queried the National Database for data from 2010 to 2017 for all LLDs. The primary outcomes were 30‐day and 90‐day readmission rates.